(The sitting was suspended at 19.25 and resumed at 21.00.)

IN THE CHAIR: Alejo VIDAL-QUADRAS ROCA
Vice-President

13. Patents for biotechnological inventions (debate)

Commission statement: Patents for biotechnological inventions

Charlie McCreevy (Member of the Commission) made the statement.

The following spoke: Peter Liese, on behalf of the PPE-DE Group, Maria Berger, on behalf of the PSE Group, Diana Wallis, on behalf of the ALDE Group, Hiltrud Breyer, on behalf of the Verts/ALE Group, Johannes Blokland, on behalf of the IND/DEM Group, Marcin Libicki, on behalf of the UEN Group, Manuel Medina Ortega, Patrizia Toia, Maciej Marian Giertych, Andrzej Jan Szejna and Kathy Sinnott.

Motions for resolutions to wind up the debate tabled pursuant to Rule 103(2):

- Diana Wallis, on behalf of the ALDE Group, on patents for biotechnological inventions (B6-0551/2005);

- Maria Berger, on behalf of the PSE Group, on patents for biotechnological inventions (B6-0552/2005);

- Hiltrud Breyer and Margrete Auken, on behalf of the Verts/ALE Group, on the legal protection of biotechnological inventions (B6-0553/2005);

-Klaus-Heiner Lehne, Jaime Mayor Oreja, Miroslav Mikolášik, Peter Liese and Giuseppe Gargani, on behalf of the PPE-DE Group, on patents for biotechnological inventions (B6-0554/2005);

- Brian Crowley, Rolandas Pavilionis and Marcin Libicki, on behalf of the UEN Group, on patents for biotechnological inventions (B6-0555/2005);

- Umberto Guidoni, Marco Rizzo, Ilda Figueiredo, Pedro Guerreiro and Sylvia-Yvonne Kaufmann, on behalf of the GUE/NGL Group, on legal protection of biotechnological inventions (B6-0556/2005);

- Bastiaan Belder, Johannes Blokland, Kathy Sinnott, Maciej Marian Giertych, Patrick Louis, Mario Borghezio, Matteo Salvini and Francesco Enrico Speroni, on behalf of the IND/DEM Group, on the patenting of biotechnological inventions (B6-0557/2005).

The debate closed.

Vote: Minutes of 26.10.2005, Item 3.8.